Proellex pharmacokinetic bridging study II
Phase of Trial: Phase I
Latest Information Update: 20 Jun 2008
At a glance
- Drugs Telapristone (Primary)
- Indications Endometriosis; Uterine leiomyoma
- Focus Pharmacokinetics
- Sponsors Repros Therapeutics
- 28 Mar 2008 The expected completion date for this trial is now 1 Apr 2008, as reported by clinicaltrials.gov.
- 28 Mar 2008 Status change from recruiting to in progress, as reported by clinicaltrials.gov.
- 26 Mar 2008 New trial record.